Results 11 to 20 of about 10,548 (182)

Impact of mechanical circulatory support on donor heart allocation: past, present, and future [PDF]

Reviews in Cardiovascular Medicine, 2021
The United Network for Organ Sharing (UNOS) recently revised its heart allocation policy to address numerous shortcomings of the previous system. Implemented in 2018, the changes sought to reduce waiting list mortality, clearly define urgency status ...
Robert T. Tatum, H. Todd Massey, Vakhtang Tchantchaleishvili   +2 more
doaj   +1 more source

Left Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm

The Thoracic & Cardiovascular Surgeon Reports, 2022
Background Left ventricular assist device (LVAD) implantation after contained LV rupture (pseudoaneurysm) represents a difficult surgical problem. Case Description We describe the surgical approach for such a patient.
Dejan Radakovic, Kiril Penov, Gülmisal Güder, Ivan Aleksic   +3 more
doaj   +1 more source

Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial Infarction. [PDF]

PLoS ONE, 2016
Left ventricular assist device (LVAD) mechanically unloads the left ventricle (LV). Theoretical analysis indicates that partial LVAD support (p-LVAD), where LV remains ejecting, reduces LV preload while increases afterload resulting from the elevation of
Keita Saku, Takamori Kakino, Takahiro Arimura, Takafumi Sakamoto, Takuya Nishikawa, Kazuo Sakamoto, Masataka Ikeda, Takuya Kishi, Tomomi Ide, Kenji Sunagawa   +9 more
doaj   +1 more source

Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation

The Egyptian Heart Journal, 2023
Background The left ventricular assist devices (LVADs) are increasingly used for advanced heart failure as a bridge to heart transplantation or as a destination therapy. The aim of this study was to investigate the changes of diastolic pulmonary gradient
Mohamed Laimoud, Emad Hakami, Mary Jane Maghirang, Tahir Mohamed   +3 more
doaj   +1 more source

Renal Dysfunction in Patients with Left Ventricular Assist Device

Methodist DeBakey Cardiovascular Journal, 2022
Late-stage heart failure and renal dysfunction are often seen in conjunction. Cardiorenal syndrome (CRS) describes the complex interaction between the two disease states.
Lamees I. El Nihum, Nina Manian, Priya Arunachalam, Qasim Al Abri, Ashrith Guha   +4 more
doaj   +1 more source

Aortic valve disorders and left ventricular assist devices

Frontiers in Cardiovascular Medicine, 2023
Aortic valve disorders are important considerations in advanced heart failure patients being evaluated for left ventricular assist devices (LVAD) and those on LVAD support. Aortic insufficiency (AI) can be present prior to LVAD implantation or develop de
Deepak Acharya, Toshinobu Kazui, Dina Al Rameni, Tushar Acharya, Edward Betterton, Elizabeth Juneman, Renzo Loyaga-Rendon, Kapildeo Lotun, Ranjith Shetty, Arka Chatterjee   +9 more
doaj   +1 more source

Uncommon Iatrogenic Devices Seen on Chest Radiographs

Indian Journal of Radiology and Imaging, 2021
Chest radiograph (CXR) is the most common imaging performed for both inpatients and outpatients. With advances in medicine and technology, newer devices/prosthesis are being used in the treatment of cardiothoracic conditions.
Vimal Raj, Santhosh Kumar DG, Richard A. Tobias   +2 more
doaj   +1 more source

Recent change in bridging strategy and improved clinical outcomes following durable left ventricular assist device implantation in Japan. [PDF]

JHLT Open
Background: Destination therapy (DT) was approved in Japan in May 2021. Use of Impella device as a bridge to left ventricular assist device (LVAD) implantation has been increasing.
Nakamura M, Imamura T, Saiki Y, Ono M, Kinugawa K, J-MACS Investigators.   +5 more
europepmc   +2 more sources

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Platelets, 2022
Left-ventricular assist devices (LVADs) improve outcomes in end-stage heart failure patients. Two centrifugal-flow LVAD systems are currently approved, HeartMate 3 (HM3) and Medtronic/Heartware HVAD (HVAD).
Maximilian Tscharre, Franziska Wittmann, Daniela Kitzmantl, Silvia Lee, Beate Eichelberger, Patricia P. Wadowski, Günther Laufer, Dominik Wiedemann, Birgit Forstner-Bergauer, Cihan Ay, Simon Panzer, Daniel Zimpfer, Thomas Gremmel   +12 more
doaj   +1 more source

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

Transplantation Direct, 2022
Background. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of ...
Thiru Chinnadurai, MD, Snehal R. Patel, MD, Omar Saeed, MD, Waqas Hanif, MD, Mercedes Rivas-Lasarte, MD, PhD, Muhammad Farooq, MD, Carolyne Castillo, BSN, RN, Maria Taveras, BSN, RN, Daphenie Fauvel, FNP-BC, Jooyoung J. Shin, MD, Daniel Sims, MD, Sandhya Murthy, MD, Sasha Vukelic, MD, PhD, Patricia Chavez, MD, Stephen Forest, MD, Daniel Goldstein, MD, Ulrich P. Jorde, MD   +16 more
doaj   +1 more source